Real time insider trading transaction history:
- Insiders are prohibited from making short-swing profits by trading their shares within 6 months of the registration or acquiring the shares.
- Shares are not adjusted for stock split.
"Insiders might sell their shares for any number of reasons, but they buy them for only one: they think the price will rise"
- Peter Lynch
What is insider trading>>
- Peter Lynch
What is insider trading>>
Common stock purchase or sale:
| Transaction Date |
Reported DateTime |
Company | Symbol | Insider Relationship |
Shares Traded |
Average Price |
Total Amount |
Shares Owned |
Filing |
| 2022-11-01 Sale |
2022-11-02 9:52 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $43.42 | $434,183 | 531,016 (Direct) |
View |
| 2022-10-03 Sale |
2022-10-05 08:55 am |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $33.23 | $332,279 | 541,016 (Direct) |
View |
| 2022-09-13 Sale |
2022-09-15 7:59 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
60,000 | $27.42 | $1,645,444 | 551,016 (Direct) |
View |
| 2022-03-01 Sale |
2022-03-02 8:40 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $17.59 | $175,900 | 609,864 (Direct) |
View |
| 2022-02-01 Sale |
2022-02-03 7:12 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $17.56 | $175,600 | 619,864 (Direct) |
View |
| 2021-01-10 Sale |
2022-01-11 9:40 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $19.55 | $195,500 | 619,864 (Direct) |
View |
| 2021-12-02 Sale |
2021-12-03 5:20 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $20.18 | $353,150 | 255,996 (Direct) |
View |
| 2021-11-02 Sale |
2021-11-03 4:16 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $22.57 | $394,975 | 273,496 (Direct) |
View |
| 2021-10-04 Sale |
2021-10-05 4:11 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $21.54 | $376,950 | 290,996 (Direct) |
View |
| 2021-09-02 Sale |
2021-09-03 4:37 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $23.89 | $418,075 | 308,496 (Direct) |
View |
| 2021-08-03 Sale |
2021-08-04 5:38 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $20.83 | $364,577 | 325,996 (Direct) |
View |
| 2021-07-02 Sale |
2021-07-06 5:52 pm |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
17,500 | $24.78 | $433,650 | 342,489 (Direct) |
View |
Stock options: Exercise, Award, Grant, Conversion
| Transaction Date |
Reported DateTime |
Exercisable Expiration |
Company | Symnbol | Insider Relationship |
Shares Traded |
Conversion Price |
Shares Owned |
Filing |
| 2022-11-01 Exercise |
2022-11-02 9:52 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 531,016 (Direct) |
View |
| 2022-11-01 Exercise |
2022-11-02 9:52 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 531,016 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-05 08:55 am |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 541,016 (Direct) |
View |
| 2022-10-03 Exercise |
2022-10-05 08:55 am |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 541,016 (Direct) |
View |
| 2022-09-13 Exercise |
2022-09-15 7:59 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
60,000 | $0 | 551,016 (Direct) |
View |
| 2022-09-13 Exercise |
2022-09-15 7:59 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
60,000 | $0.615 | 551,016 (Direct) |
View |
| 2022-09-09 Option Award |
2022-09-13 9:13 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
174,442 | $0 | 571,811 (Direct) |
View |
| 2022-06-30 Option Award |
2022-09-13 9:13 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
1,152 | $8.03 | 571,811 (Direct) |
View |
| 2022-05-24 Option Award |
2022-05-26 4:14 pm |
N/A 2032-05-23 |
Vera Therapeutics Inc. | VERA | Cheng Andrew Director |
9,925 | $0 | 9,925 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-02 8:40 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 609,864 (Direct) |
View |
| 2022-03-01 Exercise |
2022-03-02 8:40 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 609,864 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 7:12 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 619,864 (Direct) |
View |
| 2022-02-01 Exercise |
2022-02-03 7:12 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 619,864 (Direct) |
View |
| 2022-01-10 Exercise |
2022-01-11 9:40 pm |
N/A 2028-10-17 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0 | 619,864 (Direct) |
View |
| 2022-01-10 Exercise |
2022-01-11 9:40 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,000 | $0.615 | 619,864 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 9:21 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
53,000 | $0 | 514,708 (Direct) |
View |
| 2022-01-03 Exercise |
2022-01-04 9:21 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
53,000 | $0.615 | 514,708 (Direct) |
View |
| 2021-12-08 Option Award |
2021-12-10 5:15 pm |
N/A 2031-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President and CEO |
261,662 | $0 | 261,662 (Direct) |
View |
| 2021-06-03 Option Award |
2021-06-07 4:24 pm |
2021-06-03 2031-06-03 |
Arbutus Biopharma Corp | ABUS | Cheng Andrew Director |
22,000 | $0 | 22,000 (Direct) |
View |
| 2021-05-18 Conversion |
2021-05-18 8:12 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Cheng Andrew Director |
17,488 | $0 | 17,488 (Indirect) |
View |
| 2021-05-13 Option Award |
2021-05-17 8:35 pm |
N/A 2031-05-12 |
Vera Therapeutics Inc. | VERA | Cheng Andrew Director |
9,925 | $0 | 9,925 (Direct) |
View |
Ownership |
2021-05-13 7:16 pm |
N/A N/A |
Vera Therapeutics Inc. | VERA | Cheng Andrew Director |
0 | $0 | 86,531 (Indirect) |
View |
| 2021-01-07 Exercise |
2021-01-11 7:57 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
20,000 | $0 | 618,701 (Direct) |
View |
| 2020-12-31 Gift |
2021-01-11 7:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
3,000 | $0 | 618,701 (Direct) |
View |
| 2021-01-07 Exercise |
2021-01-11 7:57 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
20,000 | $0.615 | 618,701 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-29 4:53 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
7,480 | $0 | 621,701 (Direct) |
View |
| 2020-12-28 Exercise |
2020-12-29 4:53 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
7,480 | $0.62 | 621,701 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-23 4:19 pm |
N/A 2028-09-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,500 | $0 | 621,701 (Direct) |
View |
| 2020-12-11 Gift |
2020-12-23 4:19 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
2,550 | $0 | 621,701 (Direct) |
View |
| 2020-12-21 Exercise |
2020-12-23 4:19 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew President & CEO |
10,500 | $0.62 | 621,701 (Direct) |
View |
| 2020-12-08 Option Award |
2020-12-09 8:47 pm |
N/A 2030-12-07 |
Akero Therapeutics Inc. | AKRO | Cheng Andrew Chief Executive Officer |
242,500 | $0 | 570,059 (Direct) |
View |
| 2020-06-30 Option Award |
2020-12-09 8:47 pm |
N/A N/A |
Akero Therapeutics Inc. | AKRO | Cheng Andrew Chief Executive Officer |
1,245 | $17.07 | 570,059 (Direct) |
View |
| 2020-05-28 Option Award |
2020-06-01 4:58 pm |
2020-05-28 2030-05-28 |
Arbutus Biopharma Corp | ABUS | Cheng Andrew Director |
22,000 | $0 | 22,000 (Direct) |
View |